Ulrich Herrlinger

Ulrich Herrlinger

UNVERIFIED PROFILE

Are you Ulrich Herrlinger?   Register this Author

Register author
Ulrich Herrlinger

Ulrich Herrlinger

Publications by authors named "Ulrich Herrlinger"

Are you Ulrich Herrlinger?   Register this Author

95Publications

1682Reads

42Profile Views

Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.

Neuro Oncol 2019 Apr 23. Epub 2019 Apr 23.

Interdisciplinary Division of Neuro-Oncology, Departments of Neurology and Neurosurgery, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noz071DOI Listing
April 2019

Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12.

Cancers (Basel) 2019 Feb 26;11(3). Epub 2019 Feb 26.

Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11030272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468743PMC
February 2019

Prognostic Factors and Survival of Gliomatosis Cerebri: A Systematic Review and Meta-Analysis.

World Neurosurg 2018 Dec 30;120:e818-e854. Epub 2018 Aug 30.

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Unit of Clinical Epidemiology, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2018.08.173DOI Listing
December 2018

Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.

J Neurooncol 2018 Nov 16;140(2):467-475. Epub 2018 Aug 16.

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 75 M. Asias Str., 11745, Athens, Greece.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-018-2976-4
Publisher Site
http://dx.doi.org/10.1007/s11060-018-2976-4DOI Listing
November 2018

Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma.

J Clin Neurosci 2018 Jul 10;53:255-258. Epub 2018 May 10.

Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany; West German Cancer Center (WTZ) & German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Translational Oncology/Neurooncology, German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, Essen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2018.04.056DOI Listing
July 2018

Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.

J Cancer Res Clin Oncol 2017 Sep 22;143(9):1815-1821. Epub 2017 Apr 22.

Department of General Neurology, University Hospital Tuebingen, Geissweg 3, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-017-2423-5DOI Listing
September 2017

Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients.

Oncotarget 2017 Aug 27;8(32):53542-53551. Epub 2017 Jun 27.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581129PMC
August 2017

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.

Neurology 2017 Apr 15;88(15):1422-1430. Epub 2017 Mar 15.

From the Department of Neurology and Brain Tumor Center (D.G., M.W.), University Hospital Zurich and University of Zurich, Switzerland; Department of Neuroradiology (P.K., M.B.), University Hospital of Heidelberg; Institute for Medical Informatics, Statistics and Epidemiology (B.H., M.L.), University of Leipzig; Departments of Neuropathology (J.F., G.R.) and Neurosurgery (M.S.), Heinrich-Heine University Düsseldorf; Division of Neurooncology (U.H.), Department of Neurology, University Medical Center Bonn; Department of Neurosurgery (G.S.), University of Dresden; Department of Neurosurgery (J.-C.T.), Ludwig Maximilians University Munich; Department of Neurosurgery (M.W.), University Medical Center Hamburg-Eppendorf, Hamburg; Department of Neurology (U.S.), Knappschaftskrankenhaus Bochum-Langendreer, Ruhr-University Bochum; Clinical Cooperation Unit Neurooncology (W.W.), German Cancer Consortium, German Cancer Research Center, and Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg; Department of Neuropathology (T.P.), DGNN Brain Tumor Reference Center, University of Bonn Medical School; and German Cancer Consortium (G.R.), German Cancer Research Center Heidelberg, Partner Site Essen/Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003809DOI Listing
April 2017

F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumor.

Oncol Lett 2016 Dec 10;12(6):4705-4707. Epub 2016 Oct 10.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, 53127 Bonn, Germany; Stem Cell Pathologies Group, Institute of Reconstructive Neurobiology, University of Bonn Medical Center, 53127 Bonn, Germany; Clinical Cooperation Unit Neurooncology, MediClin Robert Janker Klinik, 53129 Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.5234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228534PMC
December 2016

Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases.

Neuro Oncol 2016 10 2;18(10):1462-4. Epub 2016 Sep 2.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany (S.K., M.G., U.H.); Stem Cell Pathologies Group, Institute of Reconstructive Neurobiology, Bonn, Germany (S.K., L.R, B.S., M.G.); Center of Integrated Oncology (CIO), Universities of Cologne and Bonn, Germany (S.K., N.G., M.S., U.H., M.G.); Department of Neurology, University of Cologne, Cologne, Germany (N.G.), Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich, Germany (N.G., K-J.L.); Department of Dermatology, University of Cologne, Cologne, Germany (M.S.); Neuroradiology, Department of Radiology, University of Bonn Medical Center, Bonn, Germany (E.H.); Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn Medical Center, Bonn, Germany (J.L.); Department of Nuclear Medicine, University of Bonn Medical Center, Bonn, Germany (R.A.B.); Dept. of Nuclear Medicine, University of Aachen, Aachen, Germany (K-J.L.); DKFZ-Division of Translational Oncology / Neurooncology, German Cancer Consortium (DKTK) & University Hospital Essen, Essen, Germany (B.S.); Clinical Cooperation Unit Neurooncology, MediClin Robert Janker Klinik, Bonn, Germany (M.G.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035529PMC
October 2016

Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.

J Neurooncol 2016 08 18;129(1):93-100. Epub 2016 May 18.

Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Schleusenweg 2-16, 60528, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2144-7DOI Listing
August 2016

The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.

J Cancer Res Clin Oncol 2016 Aug 18;142(8):1825-9. Epub 2016 Jun 18.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Sigmund-Freud-Straße 25, 53105, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2187-3DOI Listing
August 2016

Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.

J Cancer Res Clin Oncol 2016 Jul 21;142(7):1581-9. Epub 2016 Apr 21.

Division of Clinical Neurooncology, Department of Neurology, Medical Center Bonn, 53127, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2161-0DOI Listing
July 2016

Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.

Clin Cancer Res 2016 05 16;22(9):2190-6. Epub 2015 Dec 16.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Centre, Bonn, Germany. Center of Integrated Oncology (CIO), Universities of Cologne and Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/02/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-1334DOI Listing
May 2016

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.

J Clin Oncol 2016 05 14;34(14):1611-9. Epub 2016 Mar 14.

Ulrich Herrlinger, Niklas Schäfer, Frederic Mack, Moritz Stuplich, Sied Kebir, Torsten Pietsch, and Martin Glas, University of Bonn, Bonn; Joachim P. Steinbach and Michael W. Ronellenfitsch, University of Frankfurt, Frankfurt; Astrid Weyerbrock and Horst Urbach, University of Freiburg, Freiburg; Peter Hau and Martin Uhl, University Hospital Regensburg, Regensburg; Roland Goldbrunner and Stefan Grau, University of Cologne, Cologne; Franziska Friedrich and Rolf-Dieter Kortmann, University of Leipzig, Leipzig; Veit Rohde, University of Goettingen, Goettingen; Florian Ringel, Klinikum rechts der Isar Technical University of Munich; Oliver Schnell and Claus Belka, Ludwig Maximillian University of Munich, Munich; Uwe Schlegel, Ruhr-Universität Bochum, Bochum; Michael Sabel and Jaroslaw Maciaczyk, University of Düsseldorf, Düsseldorf; Mathias Hänel, Klinikum Chemnitz, Chemnitz; Dietmar Krex, University of Dresden, Dresden; Peter Vajkoczy, Charité, Humboldt University of Berlin, Berlin; Rüdiger Gerlach, Helios Klinikum Erfurt, Erfurt; Maximilian Mehdorn, University of Kiel, Kiel; Jochen Tüttenberg, Klinikum Idar-Oberstein, Idar-Oberstein; Regine Mayer-Steinacker, University of Ulm, Ulm; Rainer Fietkau, University of Erlangen, Erlangen; Stefanie Brehmer, University of Mannheim, Mannheim; Ralf Kohnen and Elmar Dunkl, RPS Research Germany, Nürnberg; Barbara Leutgeb and Martin Proescholdt, Roche Pharma AG, Grenzach-Wyhlen; and Walter Stummer, University of Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.4691DOI Listing
May 2016

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.

J Clin Oncol 2016 05 14;34(15):1757-63. Epub 2016 Mar 14.

Agnieszka Korfel, Antonio Pezzutto, Eckhard Thiel, and Philipp Kiewe, Charité University Medicine Berlin; Thomas Grobosch, Labor Berlin - Charité Vivantes, Berlin; Uwe Schlegel, Ruhr-Universität Bochum, Bochum; Ulrich Herrlinger and Sied Kebir, University Hospital Bonn, Bonn; Martin Dreyling, Christian Schmidt, and Luisa von Baumgarten, Hospital of the Ludwig Maximilian University München, Munich; and Peter Martus, University Tuebingen, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.9897DOI Listing
May 2016

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.

Neuro Oncol 2016 Apr 27;18(4):549-56. Epub 2016 Jan 27.

Department of Neurosurgery, Ludwig-Maximilians University Munich, Munich, Germany (B.S., J.C.T.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W., G.T., H.-G.W.); Department of Neurology, University Hospital Tübingen, Tübingen, Germany (G.T.); Department of Neurosurgery, University Hospital Frankfurt, Frankfurt am Main, Germany (C.S.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (P.H.); Department of Neurosurgery, University Hospital Düsseldorf, Düsseldorf, Germany (M.C.S.); Department of Neurology, University Hospital Bonn, Bonn, Germany (U.H.); Department of Neurosurgery, University Hospital Saarland, Homburg/Saar, Germany (R.K.); Department of Neurology, Knappschaftskrankenhaus Bochum, Bochum, Germany (U.S.); Department of Oncology, Vienna General Hospital, Vienna, Austria (C.M.); Institute of Neuropathology, University Hospital Düsseldorf, Düsseldorf, Germany (G.R.); Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany (W.W.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/early/2016/
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799687PMC
April 2016

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.

Neurology 2015 Mar 25;84(12):1242-8. Epub 2015 Feb 25.

From the Department of Hematology, Oncology and Tumor Immunology (A.K., E.T., L.F., K.J.), Charité Berlin; the Departments of Clinical Epidemiology and Applied Biostatistics (P.M.) and Hematology and Oncology (R.M.), University Tübingen; the Department of Radiotherapy and Medical Oncology (F.G.), Pius Hospital Oldenburg; the Department of Neurology (M.R.), Protestant Hospital Bielefeld; the Department of Hematology (A.R.), University Hospital Essen; the Department of Internal Medicine (B.H.), Hospital Bremen Center; the Department of Hematology and Oncology (T.F.), University Hospital Magdeburg; the Department of Neurology (T.H.), University Hospital Mainz; the Department of Hematology and Oncology (H.G.M.), Klinikum Stuttgart; the Department of Hematology and Oncology (C.J.), University Hospital Rostock; the Department of Neurology (T.B.), University Hospital Munich LMU; the Departments of Neurology (U.H., P.R., M.W.) and Radiation Oncology (M.B.), University Hospital Tübingen; the Department of Neurology (U.H.), University Bonn, Germany; the Department of Neurology (P.R., M.W.), University Hospital Zurich, Switzerland; and the Institute of Neuropathology (T.P.), University Hospital Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001395DOI Listing
March 2015

Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs.

Support Care Cancer 2014 Dec 19;22(12):3341-52. Epub 2014 Aug 19.

Department of Palliative Medicine, University Hospital of Cologne, Kerpener-Strasse 62, 50924, Cologne, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2384-zDOI Listing
December 2014

Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.

Oncology 2014 18;86(5-6):369-72. Epub 2014 Jun 18.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360295DOI Listing
September 2014

Meningitis in a pregnant woman caused by Streptococcus dysgalactiae subspecies equisimilis.

Pol J Microbiol 2013 ;62(2):217-9

Dept. of General Neurology, Hertie Insitute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
November 2013

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy.

Exp Hematol Oncol 2012 Dec 5;1(1):37. Epub 2012 Dec 5.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2162-3619-1-37DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533508PMC
December 2012

Primary CNS lymphoma: a clinician's guide.

Expert Rev Neurother 2012 Oct;12(10):1197-206

Division of Clinical Neurooncology, Department of Neurology, University Hospital of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ern.12.120DOI Listing
October 2012

Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.

J Clin Oncol 2012 Jul 11;30(21):e180-3. Epub 2012 Jun 11.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.9565DOI Listing
July 2012

Richter syndrome and brain involvement: low-grade lymphoma relapsing as cerebral high-grade lymphoma.

Acta Haematol 2012 10;127(2):93-5. Epub 2011 Dec 10.

Department of Neurology, Division of Clinical Neurooncology, University of Bonn Medical Center, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000334068DOI Listing
April 2012

Gliomatosis cerebri.

Handb Clin Neurol 2012 ;105:507-15

Department of Neurology, University of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-53502-3.00005-7DOI Listing
April 2012

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

Ann Neurol 2011 Sep 27;70(3):445-53. Epub 2011 Jun 27.

Division of Clinical Neuro-oncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.22478DOI Listing
September 2011

Non-enhancing primary CNS lymphoma.

J Neurooncol 2011 Jan 9;101(2):343-4. Epub 2010 Jun 9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0258-xDOI Listing
January 2011

[Prediction of clinical course of glioblastomas by MRI during radiotherapy].

Strahlenther Onkol 2010 Dec 29;186(12):681-6. Epub 2010 Nov 29.

Radiologische Klinik, FE Strahlentherapie, Universitätsklinik Bonn, Bonn, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-010-2156-8DOI Listing
December 2010

Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population.

J Neurooncol 2010 Nov 17;100(2):187-92. Epub 2010 Mar 17.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0154-4DOI Listing
November 2010

Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.

Int J Radiat Oncol Biol Phys 2010 Jul 14;77(3):670-6. Epub 2009 Oct 14.

Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.05.031DOI Listing
July 2010

Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status.

J Neurooncol 2010 May 20;97(3):389-92. Epub 2009 Oct 20.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn, Sigmund-Freud-Str 25, 53105 Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-0032-0DOI Listing
May 2010

Very late relapses in glioblastoma long-term survivors.

J Neurol 2009 Oct 12;256(10):1756-8. Epub 2009 May 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-009-5167-6DOI Listing
October 2009

Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.

Semin Oncol 2009 Aug;36(4 Suppl 2):S25-34

Division of Clinical Neuro-oncology, Department of Neurology, University of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2009.05.004DOI Listing
August 2009

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide.

J Clin Oncol 2009 Mar 2;27(8):1257-61. Epub 2009 Feb 2.

Division of Clinical Neurooncology, Department of Neurology, University of Bonn, Sigmund-Freud-Str 25, D-53105 Bonn, Germany.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.19.2195
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.19.2195DOI Listing
March 2009

Multimodal imaging of neural progenitor cell fate in rodents.

Mol Imaging 2008 Mar-Apr;7(2):77-91

Laboratory for Gene Therapy and Molecular Imagin, Max=Planck Institute for Neurological Research, Cologne, Germany.

View Article

Download full-text PDF

Source
November 2008

Procarbazine and CCNU as initial treatment in gliomatosis cerebri.

Oncology 2008 8;75(3-4):182-5. Epub 2008 Oct 8.

Department of Neurology, Division of Clinical Neurooncology, University of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000163057DOI Listing
November 2008

Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.

J Neurooncol 2008 Oct 28;90(1):53-5. Epub 2008 Jun 28.

Clinical Neurooncology Unit, Department of Neurology, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-008-9630-5DOI Listing
October 2008

Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis.

Cerebrovasc Dis 2008 30;26(1):23-9. Epub 2008 May 30.

Department of Neuroradiology, University of Oxford, John Radcliffe Hospital, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000135649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813800PMC
September 2008

Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.

Oncology 2007 14;72(5-6):302-7. Epub 2008 Jan 14.

Department of Neurology, University of Regensburg, Regensburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000113052DOI Listing
March 2008

Imaging-guided gene therapy of experimental gliomas.

Cancer Res 2007 Feb;67(4):1706-15

Laboratory for Gene Therapy and Molecular Imaging at the Max Planck Institute for Neurological Research, University of Cologne, Gleuelerstrasse 50, 50931 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-2418DOI Listing
February 2007

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.

J Neurooncol 2006 Nov 13;80(2):159-65. Epub 2006 May 13.

Department of Hematology, Oncology and Transfusion Medicine, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, D-12200, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-006-9165-6DOI Listing
November 2006

Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.

Leuk Lymphoma 2005 Nov;46(11):1593-8

Department of Hematology and Oncology, Tübingen University Hospital, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819050017847
Publisher Site
http://dx.doi.org/10.1080/10428190500178472DOI Listing
November 2005

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.

Ann Neurol 2005 Jun;57(6):843-7

Department of General Neurology, Hertie Institute for Clinical Brain Research, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20495DOI Listing
June 2005

Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.

Eur Neurol 2005 ;53(1):42-4

Department of Neuroradiology, Medical School, University of Tubingen, Tubingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000084264DOI Listing
May 2005

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.

J Neurooncol 2005 Apr;72(2):169-77

Department of Neuroradiology, Medical School, University of Tübingen, Tübingen, Germany. wilhelm.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-004-3390-7
Publisher Site
http://dx.doi.org/10.1007/s11060-004-3390-7DOI Listing
April 2005

Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.

Biochem Biophys Res Commun 2005 Mar;328(1):125-9

Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Hoppe-Seyler-Str. 3, D-72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2004.12.164DOI Listing
March 2005

Low-grade primary central nervous system lymphoma in immunocompetent patients.

Br J Haematol 2005 Mar;128(5):616-24

Department of Haematology, Oncology and Transfusion Medicine, Charité-Universitätsmedizin Berlin, D-12200 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2004.05361.xDOI Listing
March 2005

Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.

J Neurol 2005 Mar 23;252(3):291-9. Epub 2005 Feb 23.

Department of Neurology, Hertie Institute for Clinical Brain Research University of Tübingen Medical School, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-005-0560-2DOI Listing
March 2005

Meeting report: primary central nervous system lymphoma: standards of care and future perspectives.

Onkologie 2005 Feb 3;28(2):109-11. Epub 2005 Feb 3.

Abteilung für Allgemeine Neurologie, Hertie-Institut für Klinische Hirnforschung, Zentrum für Neurologie, Universität Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000083374DOI Listing
February 2005

UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.

J Neurooncol 2005 Feb;71(3):295-9

Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Hoppe-Seyler-Str. 3, Tübingen, D-72076, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-004-1726-yDOI Listing
February 2005

Leptomeningeal metastasis: survival and prognostic factors in 155 patients.

J Neurol Sci 2004 Aug;223(2):167-78

Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Hoppe-Seyler-Str. 3, D-72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2004.05.008DOI Listing
August 2004

MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.

J Neurooncol 2004 Jan;66(1-2):147-54

Laboratory of Molecular Neuro-Oncology, Department of Neurology, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
January 2004

Recurrent delayed brain hemorrhage over years after irradiation and chemotherapy for astrocytoma.

Eur Radiol 2003 Aug 7;13(8):1891-4. Epub 2002 Nov 7.

Department of Neuroradiology, Eberhard Karls University, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-002-1635-4DOI Listing
August 2003